Loading
Latest filing published 05 Jan 2026 for Fortress Biotech, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Jimmie Harvey on record concern Fortress Biotech, Inc., in the capacity of board member. In total, 10 filings cover trades dated from 20 February 2014 to 1 January 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 5 January 2026: a share grant, in Fortress Biotech, Inc. Typically, a trade is published a median of 38 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations